Overview
Gangliosidosis is a group of rare inherited metabolic diseases that belong to a family of conditions called lysosomal storage disorders. In these diseases, the body lacks certain enzymes needed to break down fatty substances called gangliosides, which are found mainly in the brain and nervous system. When these fats build up in cells, they cause progressive damage, especially to the brain and nerves. There are two main types: GM1 gangliosidosis and GM2 gangliosidosis. GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, while GM2 gangliosidosis includes Tay-Sachs disease and Sandhoff disease, caused by deficiencies in hexosaminidase enzymes. Each type can range from severe infantile forms to milder late-onset forms. Symptoms typically include developmental regression, seizures, vision loss, muscle weakness, and intellectual disability. In the most severe forms, symptoms begin in infancy and progress rapidly. Currently, there is no cure for gangliosidosis. Treatment focuses on managing symptoms and improving quality of life. Research into gene therapy, enzyme replacement therapy, and substrate reduction therapy is ongoing and offers hope for future treatments.
Key symptoms:
Developmental regression or loss of previously learned skillsSeizuresVision loss or blindnessCherry-red spot on the back of the eyeMuscle weakness and poor muscle toneIntellectual disabilityDifficulty swallowingExaggerated startle response to loud noisesEnlarged liver and spleenSkeletal abnormalitiesCoarse facial featuresMovement problems and stiffnessFeeding difficultiesSpeech and language problemsProgressive loss of motor skills
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
4 eventsTippi Mackenzie — PHASE1
Azafaros A.G. — PHASE3
National Human Genome Research Institute (NHGRI) — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Gangliosidosis.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Gangliosidosis.
Community
No community posts yet. Be the first to share your experience with Gangliosidosis.
Start the conversation →Latest news about Gangliosidosis
Disease timeline:
New recruiting trial: A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
A new clinical trial is recruiting patients for Gangliosidosis
New recruiting trial: A Natural History Study of the Gangliosidoses
A new clinical trial is recruiting patients for Gangliosidosis
New recruiting trial: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
A new clinical trial is recruiting patients for Gangliosidosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific type of gangliosidosis does my child have, and what does this mean for the expected disease course?,Are there any clinical trials or experimental treatments currently available that we should consider?,What therapies and supportive services should we start now to maximize quality of life?,Should other family members be tested as carriers, and what does this mean for future pregnancies?,When should we consider palliative care, and what does that involve?,What emergency signs should I watch for, and what is the plan if they occur?,Are there any dietary or nutritional interventions that could help?
Common questions about Gangliosidosis
What is Gangliosidosis?
Gangliosidosis is a group of rare inherited metabolic diseases that belong to a family of conditions called lysosomal storage disorders. In these diseases, the body lacks certain enzymes needed to break down fatty substances called gangliosides, which are found mainly in the brain and nervous system. When these fats build up in cells, they cause progressive damage, especially to the brain and nerves. There are two main types: GM1 gangliosidosis and GM2 gangliosidosis. GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, while GM2 gangliosidosis includes Tay-Sachs dis
How is Gangliosidosis inherited?
Gangliosidosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for Gangliosidosis?
Yes — 3 recruiting clinical trials are currently listed for Gangliosidosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Gangliosidosis?
25 specialists and care centers treating Gangliosidosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.